These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35394551)

  • 1. Structural and functional characterization of a hypothetical protein in the RD7 region in clinical isolates of Mycobacterium tuberculosis - an in silico approach to candidate vaccines.
    Kootery KP; Sarojini S
    J Genet Eng Biotechnol; 2022 Apr; 20(1):55. PubMed ID: 35394551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of a peptide-based vaccine from late stage specific immunogenic cross-reactive antigens of PE/PPE proteins of Mycobacterium tuberculosis.
    Medha ; Priyanka ; Sharma S; Sharma M
    Eur J Pharm Sci; 2022 Jan; 168():106051. PubMed ID: 34744006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction and analyses of HLA-II restricted Mycobacterium tuberculosis CD4
    Jia Z; Gong W; Liang Y; Wu X; Zhao W
    Biotechnol Appl Biochem; 2022 Jun; 69(3):1002-1014. PubMed ID: 33886144
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Cheng P; Wang L; Gong W
    Front Microbiol; 2022; 13():947852. PubMed ID: 35836423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a multi-epitope peptide vaccine inducing robust T cell responses against brucellosis using immunoinformatics based approaches.
    Saadi M; Karkhah A; Nouri HR
    Infect Genet Evol; 2017 Jul; 51():227-234. PubMed ID: 28411163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional, structural and epitopic prediction of hypothetical proteins of Mycobacterium tuberculosis H37Rv: An in silico approach for prioritizing the targets.
    Gazi MA; Kibria MG; Mahfuz M; Islam MR; Ghosh P; Afsar MN; Khan MA; Ahmed T
    Gene; 2016 Oct; 591(2):442-55. PubMed ID: 27374154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Designing an efficient multi-epitope vaccine against Campylobacter jejuni using immunoinformatics and reverse vaccinology approach.
    Gupta N; Kumar A
    Microb Pathog; 2020 Oct; 147():104398. PubMed ID: 32771659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational identification and characterization of antigenic properties of Rv3899c of Mycobacterium tuberculosis and its interaction with human leukocyte antigen (HLA).
    Das R; Eniyan K; Bajpai U
    Immunogenetics; 2021 Oct; 73(5):357-368. PubMed ID: 34228167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Mohinani T; Saxena A; Singh SV
    Curr Genomics; 2021 Dec; 22(7):512-525. PubMed ID: 35386432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico design of a vaccine candidate based on autotransporters and HSP against the causal agent of shigellosis, Shigella flexneri.
    León Y; Zapata L; Salas-Burgos A; Oñate A
    Mol Immunol; 2020 May; 121():47-58. PubMed ID: 32163758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico design of a multi-epitope vaccine against HPV16/18.
    Sanami S; Rafieian-Kopaei M; Dehkordi KA; Pazoki-Toroudi H; Azadegan-Dehkordi F; Mobini GR; Alizadeh M; Nezhad MS; Ghasemi-Dehnoo M; Bagheri N
    BMC Bioinformatics; 2022 Aug; 23(1):311. PubMed ID: 35918631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenic potential of latency associated antigens against Mycobacterium tuberculosis.
    Singh S; Saraav I; Sharma S
    Vaccine; 2014 Feb; 32(6):712-6. PubMed ID: 24300592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational approaches for molecular characterization and structure-based functional elucidation of a hypothetical protein from Mycobacterium tuberculosis.
    Saikat ASM
    Genomics Inform; 2023 Jun; 21(2):e25. PubMed ID: 37415455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mining the Mycobacterium tuberculosis proteome for identification of potential T-cell epitope based vaccine candidates.
    Madan R; Pandit K; Bhati L; Kumar H; Kumari N; Singh S
    Microb Pathog; 2021 Aug; 157():104996. PubMed ID: 34044044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Cytotoxic T lymphocyte (CTL) Epitope and design of an immunogenic multi-epitope of Bovine Ephemeral Fever Virus (BEFV) Glycoprotein G for Vaccine Development.
    Mollazadeh S; Bakhshesh M; Keyvanfar H; Nikbakht Brujeni G
    Res Vet Sci; 2022 May; 144():18-26. PubMed ID: 35033847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting promiscuous antigenic T cell epitopes of Mycobacterium tuberculosis mymA operon proteins binding to MHC Class I and Class II molecules.
    Saraav I; Pandey K; Sharma M; Singh S; Dutta P; Bhardwaj A; Sharma S
    Infect Genet Evol; 2016 Oct; 44():182-189. PubMed ID: 27389362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prioritization of potential vaccine candidates and designing a multiepitope-based subunit vaccine against multidrug-resistant Salmonella Typhi str. CT18: A subtractive proteomics and immunoinformatics approach.
    Chand Y; Singh S
    Microb Pathog; 2021 Oct; 159():105150. PubMed ID: 34425197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of a new multi-epitope vaccine against
    Chen Z; Zhu Y; Sha T; Li Z; Li Y; Zhang F; Ding J
    Epidemiol Infect; 2021 May; 149():e136. PubMed ID: 34032200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine potential of ESAT-6 protein fused with consensus CD4
    Choi SY; Kwon KW; Kim H; Choi HH; Shin SJ
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2195-2201. PubMed ID: 29894686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.